| P2093 | author name string | Jin Gohda | |
| | Jun-Ichiro Inoue | |
| | Yuu Taguchi | |
| | Yoko Kiga | |
| P2860 | cites work | CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 |
| | TAK1 is a ubiquitin-dependent kinase of MKK and IKK | Q24291454 |
| | The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis | Q24297505 |
| | A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes | Q24299311 |
| | Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 | Q24300916 |
| | Central control of fever and female body temperature by RANKL/RANK | Q24321735 |
| | The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes | Q24338639 |
| | Genetic applications of an inverse polymerase chain reaction | Q24532247 |
| | Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 | Q24537518 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Bisphosphonates: mechanism of action and role in clinical practice | Q24644708 |
| | Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40 | Q24676338 |
| | Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice | Q28140546 |
| | The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 |
| | Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain | Q28142613 |
| | Bisphosphonates: from bench to bedside | Q28251212 |
| | Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 |
| | Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region | Q28511583 |
| | TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 |
| | Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery | Q31577177 |
| | Therapeutic approaches to bone diseases | Q34021178 |
| | NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation | Q34565548 |
| | Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics | Q35571380 |
| | Tat peptide-mediated cellular delivery: back to basics | Q36049561 |
| | TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo | Q36375923 |
| | Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis | Q36402845 |
| | Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice | Q37143375 |
| | Characterization of the mouse tartrate-resistant acid phosphatase (trap) gene promoter | Q38297200 |
| | Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator | Q38363724 |
| | PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. | Q38744013 |
| | Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis | Q39714931 |
| | Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling | Q39785295 |
| | Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. | Q40370662 |
| | Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene | Q40811962 |
| | Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts | Q40862968 |
| | RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. | Q41107411 |
| | Autoamplification of NFATc1 expression determines its essential role in bone homeostasis | Q42972503 |
| | Renal Failure with the Use of Zoledronic Acid | Q44628533 |
| | Alendronate and risedronate: reports of severe bone, joint, and muscle pain | Q45264997 |
| | Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis | Q46620740 |
| | Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans | Q46758321 |
| | Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL. | Q46960866 |
| | Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis | Q47761859 |
| | The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. | Q51949099 |
| | A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals. | Q53364532 |
| | Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand | Q64378984 |
| | A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract | Q73166731 |
| | Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL) | Q73907464 |
| | Dendritic cell development and survival require distinct NF-kappaB subunits | Q77704364 |
| | CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells | Q78068575 |
| | Constructing recombinant DNA molecules by PCR | Q80674300 |
| | A novel receptor activator of NF-kappaB (RANK) cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage | Q82062490 |
| P433 | issue | 5 | |
| P304 | page(s) | 543-553 | |
| P577 | publication date | 2012-04-28 | |
| P1433 | published in | Journal of Bone and Mineral Metabolism | Q15767236 |
| P1476 | title | Identification and characterization of anti-osteoclastogenic peptides derived from the cytoplasmic tail of receptor activator of nuclear factor kappa B | |
| P478 | volume | 30 | |